Feline_STS_histotripsy_1 31 23.pdf (8.8 MB)

Histotripsy Ablation for the Treatment of Feline Injection Site Sarcomas: A First-in-Cat In Vivo Feasibility Study

Download (8.8 MB)

Feline soft tissue sarcoma (STS) and injection site sarcoma (fISS) are rapidly growing tumors with low metastatic potential, but locally aggressive behavior. Histotripsy is a non-invasive focused ultrasound therapy using controlled acoustic cavitation to mechanically disintegrate tissue. In this study, we investigated the in vivo safety and feasibility of histotripsy to treat fISS using a custom 1 MHz transducer. Three cats with naturally-occurring STS were treated with histotripsy before surgical removal of the tumor 3 to 6 days later. Gross and histological analyses were used to characterize the ablation efficacy of the treatment, and routine immunohistochemistry and batched cytokine analysis were used to investigate the acute immunological effects of histotripsy. Results showed that histotripsy ablation was achievable and well-tolerated in all three cats. Precise cavitation bubble clouds were generated in all patients, and hematoxylin & eosin stained tissues revealed ablative damage in targeted regions. Immunohistochemical results identified an increase in IBA-1 positive cells in treated tissues, and no significant changes in cytokine concentrations were identified post-treatment. Overall, the results of this study demonstrate the safety and feasibility of histotripsy to target and ablate superficial feline STS and fISS tumors and guide the clinical development of histotripsy devices for this application. 


The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health

National Center for Advancing Translational Sciences

Find out more...

Institutional Career Development Core

National Center for Advancing Translational Sciences

Find out more...

Focused Ultrasound Foundation #453137


Email Address of Submitting Author

ORCID of Submitting Author


Submitting Author's Institution

Virginia Tech

Submitting Author's Country

  • United States of America

Usage metrics